ETV6 and congenital fibrosarcoma: The catalytically active ETV6-NTRK3 fusion proteins have been previously detected in non-hematopoietic tumors, e.g. secretory breast carcinoma and congenital fibrosarcoma and in only one single case of hematological malignancy, i.e. an AML [11-13].